ArticleInternational journal of clinical oncology2025
Factors associated with primary resistance to enfortumab vedotin in previously treated patients with metastatic urothelial carcinoma: a multicenter retrospective study.
Daiki Ikarashi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.